Triple Antibiotic Plus Lidocaine Ointment
FDA Label NDC 69396-154

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Trifecta Pharmaceuticals Usa Llc for the product Triple Antibiotic Plus Lidocaine (NDC 69396-154). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients (each gram contains), purpose, active ingredient, uses, keep out of reach of children, warnings, ask doctor before use if you have, do not use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients (Each Gram Contains)

Bacitracin zinc 500 units
Neomycin sulfate 3.5 mg
Polymyxin B sulfate 10,000 units

Purpose

First aid antibiotic

External Analgesic

Uses

Uses first aid to help prevent infection and for the temporary relief of pain or discomfort in minor:● cuts ● scrapes ● burns

Keep Out Of Reach Of Children

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Warnings

For external use only.

Directions

  • Adults and Children 2 years of age and older
  • Clean the affected area
  • Apply a small amount of this product ( an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily
  • May be covered with a sterile bandage
  • Children under 2 years of age, Ask a doctor

Questions

Questions? Call 1-888-296-9067

Inactive Ingredient

Petrolatum

Other Information


● store at 20° to 25°C ( 68° to 77°F)

* Lidocaine known in 30 to 60 minutes.

Distributed By

Distributed by:
Trifecta Pharmaceuticals USA®
101 NE Third Avenue, Suite 1500
Ft. Lauderdale, FL 33301, USA
1-888-296-9067

* This product is not manufactured or distributed by Johnson & Johnson Corporation, owner of the registered trademark Neosporin® plus Lidocaine

* Please review the disclaimer below.